International Society of Fish and Shellfish Immunology’s Post

🌟 Happy Europe Day 2024! 🌟 📅 Today we celebrate unity in diversity, innovation and collaboration across the continent. As projects funded under the same Horizon Europe call topic: "Personalised blueprint of chronic inflammation in health-to-disease transition", we're proud to contribute to the common goals of understanding the risk factors that trigger the transition from health to disease, providing personalised prevention measures and reducing the burden of chronic diseases. In GlycanTrigger EU Project, we aim to find a way to intercept chronic inflammation by studying how changes in the composition of glycans that attach to the lining of the gut impact the initiation of the inflammatory process. The project’s long-term goal is to understand the contribution of gut mucosa glycome in health to intestinal inflammation transition aiming to figure out how to turn off this process by developing novel preventive intervention strategies 🎉 Join us in celebrating this special day by exploring the impactful work of our sister projects ENDOTARGET EU Project , IMMEDIATE EU Project, miGut-Health, AIDA EU project, PREVALUNG EU, PRAESIIDIUM, CARE-IN-HEALTH, Intercept-T2D, iPROLEPSIS, @INITIALISE, HaltRONIN Horizon Together, we're shaping the future of Europe through groundbreaking research and fostering connections across borders. Let's continue to work hand in hand for a brighter, more inclusive and sustainable Europe! 🤗 #EuropeDay #HorizonEurope #EUSisterProjects

🌟 Happy Europe Day 2024! 🌟 📅 Today we celebrate unity in diversity, innovation and collaboration across the continent. As projects funded under the same Horizon Europe call topic: "Personalised blueprint of chronic inflammation in health-to-disease transition", we're proud to contribute to the common goals of understanding the risk factors that trigger the transition from health to disease, providing personalised prevention measures and reducing the burden of chronic diseases. In ENDOTARGET EU Project, we aim to study the significance of gut microbiota as a driver of chronic systemic inflammation and the role of microbiota in the pathogenesis of rheumatic diseases. With our unique consortium of diverse experts from 8 European countries, we are strengthening international and cross-border collaboration to advance research, technology and social progress in Europe and beyond. 🎉 Join us in celebrating this special day by exploring the impactful work of our sister projects GlycanTrigger EU Project, IMMEDIATE EU Project, miGut-Health, AIDA EU project, PREVALUNG EU, PRAESIIDIUM, CARE-IN-HEALTH, Intercept-T2D, iPROLEPSIS, INITIALISE, HaltRONIN-HORIZON. Together, we're shaping the future of Europe through groundbreaking research and fostering connections across borders. Let's continue to work hand in hand for a brighter, more inclusive and sustainable Europe! 🤗 Hashtag #EuropeDay #HorizonEurope #EUSisterProjects

"What will the future bring?" is what we will be hearing about on Day 2 of #PVWorld In the world of #GenAI how can #Pharmacovigilance be more proactive than reactive through #collaboration. #PVWorld #pharmacovigilance #linguamatics

🌟 Happy Europe Day 2024! 🌟 📅 Today we celebrate unity in diversity, innovation and collaboration across the continent. As projects funded under the same Horizon Europe call topic: "Personalised blueprint of chronic inflammation in health-to-disease transition", we're proud to contribute to the common goals of understanding the risk factors that trigger the transition from health to disease, providing personalised prevention measures and reducing the burden of chronic diseases.   In IMMEDIATE, we aim to identify individual biomarkers of risk and resilience against chronic inflammation by investigating the diet-microbiome-metabolite-immune axis. This complex interaction refers to how an individual's diet, gut microbiota, metabolites, and immune system can influence their health. 🎉 Join us in celebrating this special day by exploring the impactful work of our sister projects GlycanTrigger EU Project, ENDOTARGET EU Project, miGut-Health, AIDA EU project, PREVALUNG EU, PRAESIIDIUM, CARE-IN-HEALTH, Intercept-T2D, iPROLEPSIS, INITIALISE, HaltRONIN-HORIZON. Together, we're shaping the future of Europe through groundbreaking research and fostering connections across borders. Let's continue to work hand in hand for a brighter, more inclusive and sustainable Europe! 🤗 #EuropeDay #HorizonEurope #EUSisterProjects

🔬 𝑫𝒂𝒚 𝟏 𝒐𝒇 𝑨𝒅𝒗𝒂𝒏𝒄𝒆𝒅 𝑻𝒉𝒆𝒓𝒂𝒑𝒊𝒆𝒔 💉 I'm thrilled to be representing Personalize My Medicine at Advanced Therapies today! We're diving deep into the exciting world of cell and gene therapy, exploring its potential for various diseases like brain disorders, rare respiratory disease, Parkinson's disease, etc. The discussions around gene editing, CRISPR/Cas9, gene silencing (GEIS), and viral vector delivery have been incredibly insightful. These innovative approaches hold immense promise for personalised medicine, offering a potential cure for previously untreatable conditions. I'm energised by the collaborative spirit to overcome challenges and make these therapies accessible for patients. Stay tuned for more updates on Personalize My Medicine's role in advancing this revolutionary field! #cellandgenetherapy #personalizedmedicine #PersonalizeMyMedicine #geneediting #GEIS #viralvectors #braindisease #rarespiratorydisease #ParkinsonsDisease Advanced Therapies Congress

📢 At #UniteToFight2024, Stichting Long Covid shares their efforts to advance research, treatment, and awareness for #LongCOVID in the Netherlands. 📽️ Watch now: https://lnkd.in/epdWEF29

Looking forward to my first DIA Global Annual Meeting. I want to hear more about what Sponsors are doing to solve the expensive problems of poor adherence, compliance, and retention in clinical trials. What's working and what's not working? #DIA2024 #clinicaltrials #adherence

In an interview with Medical Channel Asia, Dr Pascal Rey-Herme addresses how International SOS has expanded significantly since its inception, and how International SOS has evolved to meet the changing needs of organisations, and for future growth. Watch the interview here: https://okt.to/4TJwCn #aboutus #workforceresillience

Can’t wait to present on a topic close to my heart, Modernising the SOC through the implementation of a Security Data Pipeline for the Health and Pharma sector. It’s a game changer in addressing Observability across the business, reducing SIEM log storage costs by up to 70-80% whilst adding new data sources that were previously unaffordable !! A win win ! Security Risk Advisors #securitydatapipeline #databroker #observability #databacklog #modernsoc #transformsecurityoperations

❗ European Helicobacter and Microbiota Study group (EHMSG) is a TOGAS partner with the responsibility of organizing the annual September stakeholder outreach conferences. January, 2024 the Board of EHMSG together with the scientific coordinator of the project M.Leja have been meeting in Porto, 🇵🇹 to plan the upcoming meeting in 2024. It was decided to have the meeting September 12, 2024 in Porto 🇵🇹 The potential conference sessions and speakers were discussed. The group evaluated the previous 2023 conference in Antwerp 🇧🇪 as s success. ○      @European Health and Digital Executive Agency @togas-eu-project #HealthUnion #EU4Health #EUCancerPlan